The Choice of Immunosuppressive Therapy Depending on the Level of Anti-Hla Antibodies in Kidney Transplantation

Transplantologiya
doi 10.23873/2074-0506-2018-10-1-35-41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IPO Association of Transplantologists

Related search

Donor-Specific Anti-Hla Antibodies and …Recipient-Specific Anti-Hla Antibodies? The Conundrum on Pregnancy in Transplantation

American Journal of Hematology
Hematology
2020English

The Kinetics of Anti-Hla Antibodies in the First Year After Kidney Transplantation: In Whom and When Should They Be Monitored?

Journal of Transplantation
2018English

Reporting Quality-Of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

American Journal of Kidney Diseases
Nephrology
2016English

Specificity and Sensitivity of Screening for Anti-Hla Antibodies in Kidney Allograft Dysfunction

Transplantation Proceedings
SurgeryTransplantation
2009English

The Individual Tailoring of Immunosuppressive Therapy After Heart Transplantation

Vestnik Transplantologii i Iskusstvennykh Organov
AllergyImmunologyTransplantation
2018English

Experience of Immunosuppressive Therapy in Partial Liver Transplantation.

Japanese Journal of Clinical Immunology
1991English

Detection of Anti-Hla Antibodies by Flow Cytometer

2016English

Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2016English

The Tumor Immunosuppressive Microenvironment Impairs the Therapy of Anti-Her2/Neu Antibody

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy